The global spatial genomics & transcriptomics market was valued at US$ 173.6 Million in 2020 and is expected to reach US$ 602.7 Million by 2028; registering a CAGR of 16.8% from 2021 – 2028.
Spatial genomics & transcriptomics are a new frontier in molecular biology which not only allows seeing the components of the cell but also how the cells are related to each other in an organized manner. Spatial genomics & transcriptomics is a process of staining nucleic acids at their original location within the cell or tissue. This process further helps the researchers to understand the disease using the data provided by spatial genomics & transcriptomics that was quite tough with earlier methods. Spatial genomics & transcriptomics includes the exploration and assortment of transcriptomics. Also, spatial genomics & transcriptomics has a vast application, especially in molecular genetics. The increase in governmental fundings in the Research & Development of genomics projects, the high prevalence of cancer, the hike in the application of NGS in research of cancer, and the rising applications of genomics are further driving the global spatial genomics & transcriptomics market. However, market players are introducing new products like Dovetail Genomics introduced Dovetail HiChIP and Micro-C Kits in February 2020, and NuGEN Technologies, Inc. launched Trio RNA-Seq which is highly beneficial in low-abundance transcript applications owing to its high sensitivity of transcriptomics solutions.
The massive initiative in fundings has led to the increment in the usage of genomic products globally. Prevalence in genetic disorders, neurological disorders, cancer, and advancements in technology in the genetic engineering space is responsible for market growth. Extensive investments in the field of genomics, major involvement of the government in the introduction of new technologies, and a hike in the fundings for genomic projects from the government are driving the global spatial genomics & transcriptomics market growth.
However, the limited resources and lack of skilled professionals are producing hurdles in the growth of the global market. Even in developed economies the development of genomics is very restricted in comparison to other research sectors. Lack of specialized laboratories especially in developing economies, limited availability of resources, lack of skilled labor, lack of researchers & technicians, give rise to limited productivity which hinders the growth of the global spatial genomics & transcriptomics market.
The advancements in gene therapy are expected to replace surgeries and traditional drugs by allowing doctors to treat the deformities by inserting the genes into the patient’s cell. Usage of genomics for personalized/specialized medicines owing to its cost-effectiveness, drug safety, early detection of diseases, and patient compliance will provide lucrative opportunities for the market players. Furthermore, an increase in the collaborations, acquisitions, and partnerships between various countries and research institutes is anticipated to positively impact the growth of the global spatial genomics & transcriptomics market.
The global spatial genomics & transcriptomics market is fragmented on the basis of Technique, Product, Application, End-user, and Region. By Techniques, the global spatial genomics & transcriptomics market is segmented into spatial transcriptomics techniques and spatial genomics analysis techniques. Spatial transcriptomics is further sub-segmented into Microscopy-based RNA Imaging, Immunohistochemistry (IHC), In Situ Hybridization, and Sequencing Technologies. Whereas, Spatial genomics analysis techniques are further sub-segmented into Fluorescence In Situ Hybridization (FISH), Sequencing Techniques. Based on Technique, the spatial transcriptomics techniques segment holds the largest market share owing to the high adoption rate of in situ sequencing techniques globally. Based on Product, the spatial genomics & transcriptomics market is classified into consumables, instruments, and software. By Product segment, consumables accounted for the largest share in the market because of the applications of consumables in fields like drug discovery & biomarker identification. The Application segment is further sub-segmented into translational research and drug discovery & development. Among Application types, the translational research application segment dominates the global market. Based on End-user, the global market is segmented into contract research organizations (CROs), academic & research institutes, biotechnology, and pharmaceutical companies.
Based on region, the global spatial transcriptomics market is segmented into North America, Europe, Asia-Pacific (APAC), and RoW. North America is further classified into U.S. & Canada. Europe is further segmented into Germany, the U.K., Italy, Spain, Russia, France, rest of Europe. Asia-Pacific is segmented into China, Japan, India, Australia, South Korea, rest of APAC. RoW covers South & Central America, the Middle East, and Africa. Currently, North America dominates the global market owing to the active market players in the region. APAC to register the highest CAGR in the forecast period 2021 – 2028.
The prominent players of the global spatial transcriptomics market are S2 Genomics, Illumina, Inc., Dovetail Genomics, NuGEN Technologies, Inc., Horizon Discovery Group plc, Bio-Rad Laboratories, NanoString Technologies Inc., 10X Genomics, Seven Bridges Genomics, and Natera Inc. among others.
Market Segmentation and Scope of the Global Spatial Transcriptomics Market:
Prominent Players in the global Spatial Genomics Transcriptomics Market: